![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
| Name: | Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide) |
| Catalogue No. | VL197024 |
| CAS No. | N/A |
| Molecular Formula | C18H16N2O4 |
| Molecular Weight | 324.33 g/mol |
| Status | In-Stock |
| IUPAC Name | N-(3-hydroxyphenyl)-3-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)propanamide |
| Description | Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)()or N-(3-hydroxyphenyl)-3-((2-oxo-1,2-dihydroquinolin-7-yl)oxy)propanamide. it is an antipsychotic drug is associated with serious psychiatric treatment failure. |
| References | Montastruc, François, et al. “Association of Aripiprazole with the Risk for Psychiatric Hospitalization, Self-Harm, or Suicide.” JAMA Psychiatry, vol. 76, no. 4, Apr. 2019, p. 409, https://doi.org/10.1001/jamapsychiatry.2018.4149. |
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)